期刊文献+

变应性鼻炎的非特异性免疫治疗进展 被引量:4

The progress of the nonspecific immune therapy of allergic rhinitis
原文传递
导出
摘要 变应性鼻炎(allergic rhinitis,AR)是特应性个体接触致敏原后由IgE介导的递质释放,并由多种免疫活性细胞和细胞因子等参与的鼻黏膜慢性炎症反应性疾病〔1〕。随着人们的居住环境和生活条件的改变,AR成为了一个全球性的健康问题,影响至少10%~25%的人口〔2〕。AR目前的治疗方法主要有避免接触变应原, Summary The article describes immune disorder mechanisms of allergic rhinitis and the progress and clinical application status of the nonspecific immune therapy of allergic rhinitis,which can raise people's understanding about the nonspecific immune therapy of this disease.
出处 《临床耳鼻咽喉头颈外科杂志》 CAS 北大核心 2013年第15期857-860,共4页 Journal of Clinical Otorhinolaryngology Head And Neck Surgery
关键词 鼻炎 变应性 免疫调节 非特异性免疫治疗 rhinitis, allergic immune modulations nonspecific immune therapy
  • 相关文献

参考文献3

二级参考文献6

  • 1韩德民,张罗,黄丹,武阳丰,董震,许庚,孔维佳,暴继敏,周兵,汪审清,王德辉,王秋萍.我国11个城市变应性鼻炎自报患病率调查[J].中华耳鼻咽喉头颈外科杂志,2007,42(5):378-384. 被引量:404
  • 2Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update ( in collaboration with the World Health Organization, GAELEN and AllerGen). Allergy, 2008, 63(Suppl 86) :8-160. 被引量:1
  • 3Alvarez-Cuesta E, Bousquet J, Canoniea GW, et al. Standards for practical allergen-specific immunotherapy. Allergy, 2006, 61 ( Suppl 82) : 1-20. 被引量:1
  • 4Bousquet PJ, Combescure C, Neukirch F, et al. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy, 2007, 62 : 367-372. 被引量:1
  • 5Umetsu D T,DeKruyff R H. Th1 and Th2 CD4^+ cells in human allergic diseases. J Allergy Clin Immunol, 1997,100:1-6. 被引量:1
  • 6赵邠兰,顾之燕.变应性鼻炎基础和临床研究进展[J].中华耳鼻咽喉科杂志,1999,34(5):270-271. 被引量:47

共引文献854

同被引文献56

  • 1刘金垒,但文超,何庆勇,曲艺.基于国家专利中药复方治疗过敏性鼻炎用药规律与机制研究[J].辽宁中医药大学学报,2020(8):134-139. 被引量:15
  • 2VARSHNEY J,VARSHNEY H.Allergic rhinitis:an overview[J].Indian J Otolaryngol Head Neck Surg,2005,67:143-149. 被引量:1
  • 3KLIMEK L,MULLOL J,HELLINGS P,et al.Recent pharmacological developments in the treatment of perennial and persistent allergic rhinitis.[J].Expert Opin Pharmacother,2016,17:657-669. 被引量:1
  • 4INCORVAIA C,ARIANO R,BERTO P,et al.Economic aspects of sublingual immunotherapy[J].Int JImmunopathol Pharmacol,2009,22:27-30. 被引量:1
  • 5MOHAPATRA S S,QAZI M,HELLERMANN G.Immunotherapy for allergies and asthma:present and future[J].Curr Opin Pharmacol,2010,10:276-288. 被引量:1
  • 6PAJNO G B,NADEAU K C,PASSALACQUA G,et al.The evolution of allergen and non-specific immunotherapy:past achievements,current applications and future outlook[J].Expert Rev Clin Immunol,2015,11:141-154. 被引量:1
  • 7HAYASHI T,RAZ E.TLR9-based immunotherapy for allergic disease[J].Am J Med,2006,119:e1-6. 被引量:1
  • 8LI D Q,ZHANG L,PFLUGFELDER S C,et al.Short ragweed pollen triggers allergic inflammation through Toll-like receptor 4-dependent thymic stromal lymphopoietin/OX40 ligand/OX40 signaling pathways[J].J Allergy Clin Immunol,2011,128:1318-1325. 被引量:1
  • 9CASALE T B,KESSLER J,ROMERO F A.Safety of the intranasal toll-like receptor 4agonist CRX-675in allergic rhinitis[J].Ann Allergy Asthma Immunol,2006,97:454-456. 被引量:1
  • 10MELVIN T A,RAMANATHAN M J R.Role of innate immunity in the pathogenesis of allergic rhinitis[J].Curr Opin Otolaryngol Head Neck Surg,2012,20:194-198. 被引量:1

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部